Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer
Condition: Endometrial CancerInterventions: Drug: cediranib maleate; Other: laboratory biomarker analysisSponsors: Gynecologic Oncology Group; National Cancer Institute (NCI)Recruiting - verified August 2010






